Home LiteratureArticle Details
PMID: 12009895 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Plasma membrane phospholipid scramblase 1 is enriched in lipid rafts and interacts with the epidermal growth factor receptor.

Biochemistry ·Vol. 41 ·No. 20 ·2002-05-21 ·Pages 6338-45

Sun J, Nanjundan M, Pike LJ, Wiedmer T, Sims PJ

Abstract

We have identified physical and functional interactions between the epidermal growth factor (EGF) receptor and phospholipid scramblase 1 (PLSCR1), an endofacial plasma membrane protein proposed to affect phospholipid organization. PLSCR1, a palmitoylated protein, was found to partition with the EGF receptor in membrane lipid rafts. Cell stimulation with EGF transiently elevated Tyr-phosphorylation of PLSCR1, peaking at 5 min. Although PLSCR1 is a known substrate of c-Abl [Sun, J., et al. (2001) J.Biol. Chem. 276, 28984-28990], the Abl inhibitor STI571 did not substantially affect its EGF-dependent phosphorylation, suggesting PLSCR1 is a substrate of the EGF receptor kinase, or another EGF-activated kinase. Coinciding with phosphorylation, there was a transient increase in physical association of PLSCR1 with both the EGF receptor and the adapter protein Shc, as determined by immunoprecipitation and Western blotting. Confocal immunofluorescence analysis revealed that EGF initiates rapid internalization of both the EGF receptor and PLSCR1, with trafficking into both distinct and common endosomal pools. These data also suggested that whereas the EGF receptor is ultimately degraded, much of the endocytosed PLSCR1 is recycled to the cell surface within 3 h after EGF treatment. Consistent with this interpretation, Western blotting revealed neither ubiquitination nor proteolysis of PLSCR1 under these conditions, whereas the ubiquitination and degradation of the EGF receptor were readily confirmed. Finally, stimulation with EGF was also found to markedly increase the total cellular expression of PLSCR1, suggesting that in addition to its initial interactions with activated EGF receptor, PLSCR1 may also contribute to posttranscriptional effector pathway(s) mediating the cellular response to EGF.

MeSH Terms
Carrier Proteins/biosynthesis,metabolism,physiology Endocytosis/physiology Epidermal Growth Factor/pharmacology ErbB Receptors/metabolism Humans KB Cells Membrane Microdomains/enzymology,metabolism Membrane Proteins/biosynthesis,metabolism,physiology Phospholipid Transfer Proteins Phospholipids/metabolism Phosphorylation Phosphotyrosine/metabolism Proto-Oncogene Proteins c-abl/physiology
Chemicals
Carrier Proteins Membrane Proteins Phospholipid Transfer Proteins Phospholipids Phosphotyrosine Epidermal Growth Factor ErbB Receptors Proto-Oncogene Proteins c-abl
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sun Jun
Department of Molecular & Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
Nanjundan Meera
Pike Linda J
Wiedmer Therese
Sims Peter J
Article Info
Journal
Biochemistry
Abbr.
Biochemistry
ISSN
0006-2960
Published
2002-05-21
Pages
6338-45
Language
English
Region
United States
NLM ID
0370623
Subset
IM
Grants
NIGMS NIH HHS · GM56329 · United States
NHLBI NIH HHS · HL36496 · United States
NHLBI NIH HHS · HL61200 · United States
NHLBI NIH HHS · HL63819 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com